首页> 美国卫生研究院文献>EXCLI Journal >Evaluation of microsatellite instability in tumor and tumor marginal samples of sporadic colorectal cancer using mononucleotide markers
【2h】

Evaluation of microsatellite instability in tumor and tumor marginal samples of sporadic colorectal cancer using mononucleotide markers

机译:使用单核苷酸标记物评估散发性结直肠癌的肿瘤和肿瘤边缘样品中的微卫星不稳定性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microsatellite instability (MSI) is a unique molecular alteration that is due to a defective DNA mismatch repair (MMR) system. Approximately, 15-20 % of sporadic colorectal cancers (CRC) display MSI. Determination of MSI status in CRC has prognostic and predictive implications. Additionally, detecting MSI is used diagnostically for tumor detection and classification. The present study analyzed a panel of five mononucleotide markers, BAT-25, BAT-26, NR-21, NR-22 and NR-27, amplified in a single multiplex PCR reaction to evaluate MSI status in CRC patients. Genomic DNA from 50 CRC and paired adjacent normal tissues was used for PCR-based MSI analysis. Our finding showed microsatellite instability in 36 % of specimens. Instability with differences in allele lengths was observed in the tumoral DNA compared to the tumor-free margin DNA sample. The frequency of instability in NR-21, BAT-26 and BAT-25 markers were more than others; their frequency were 35.48 %, 29.03 %, and 22.58 %, respectively. In conclusion, the NR-21, BAT-26, and BAT-25 were the most useful markers for discriminating cancer tissue from normal, therefore these markers have demonstrated promising potential for determining MSI status in patients with sporadic colorectal cancer.
机译:微卫星不稳定性(MSI)是独特的分子改变,这是由于DNA错配修复(MMR)系统存在缺陷所致。大约有15-20%的散发性结直肠癌(CRC)显示MSI。 CRC中MSI状态的确定具有预后和预测意义。另外,检测MSI在诊断上用于肿瘤的检测和分类。本研究分析了一组5种单核苷酸标记物BAT-25,BAT-26,NR-21,NR-22和NR-27,这些标记物在单次多重PCR反应中扩增以评估CRC患者的MSI状况。来自50个CRC和配对的邻近正常组织的基因组DNA用于基于PCR的MSI分析。我们的发现显示36%的标本中微卫星不稳定。与无肿瘤的边缘DNA样品相比,在肿瘤DNA中观察到了等位基因长度不同的不稳定性。 NR-21,BAT-26和BAT-25标记的不稳定性频率比其他标记高。它们的频率分别为35.48%,29.03%和22.58%。总之,NR-21,BAT-26和BAT-25是区分癌组织与正常组织的最有用的标志物,因此这些标志物已显示出确定散发性结直肠癌患者MSI状况的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号